National Health Investors Stock Profit Margin
WX6 Stock | EUR 69.00 1.00 1.43% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National |
National Health Investors Company Profit Margin Analysis
National Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current National Health Profit Margin | 0.24 % |
Most of National Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, National Health Investors has a Profit Margin of 0.2382%. This is 97.74% lower than that of the Real Estate sector and 99.31% lower than that of the REIT - Healthcare Facilities industry. The profit margin for all Germany stocks is 118.76% lower than that of the firm.
National Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in profit margin category among its peers.
National Fundamentals
Return On Equity | 0.0467 | |||
Return On Asset | 0.0336 | |||
Profit Margin | 0.24 % | |||
Operating Margin | 0.52 % | |||
Current Valuation | 3.32 B | |||
Shares Outstanding | 43.39 M | |||
Shares Owned By Insiders | 4.77 % | |||
Shares Owned By Institutions | 63.16 % | |||
Price To Earning | 19.80 X | |||
Price To Book | 1.86 X | |||
Price To Sales | 8.22 X | |||
Revenue | 278.19 M | |||
Gross Profit | 268.98 M | |||
EBITDA | 178.82 M | |||
Net Income | 66.4 M | |||
Cash And Equivalents | 5.74 M | |||
Cash Per Share | 0.13 X | |||
Total Debt | 1.15 B | |||
Debt To Equity | 91.00 % | |||
Current Ratio | 2.21 X | |||
Book Value Per Share | 29.27 X | |||
Cash Flow From Operations | 185.34 M | |||
Earnings Per Share | 1.41 X | |||
Target Price | 69.14 | |||
Number Of Employees | 25 | |||
Beta | 0.94 | |||
Market Capitalization | 2.28 B | |||
Total Asset | 2.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.07 % | |||
Net Asset | 2.51 B | |||
Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in National Stock
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.